📗 Cite This Artifact
TNF Alpha Protein
TNF Alpha Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TNF Alpha Protein</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TNF</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Tumor Necrosis Factor Alpha</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P01375</td>
</tr>
<tr>
<td class="label">Length</td>
<td>233 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>25.6 kDa (monomer), 52.4 kDa (trimer)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6p21.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>7124</td>
</tr>
<tr>
<td class="label">Cellular Localization</td>
<td>Secreted (type II transmembrane protein)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TNF Superfamily</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TNFRSF1A (TNFR1)</td>
<td>Receptor binding</td>
</tr>
<tr>
<td class="label">TNFRSF1B (TNFR2)</td>
<td>Receptor binding</td>
</tr>
<tr>
<td class="label">TNFRSF1B</td>
<td>Decoy receptor</td>
</tr>
<tr>
<td class="label">TRADD</td>
<td>Adapter protein</td>
</tr>
<tr>
<td class="label">RIPK1</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">TRAF2</td>
<td>Adapter protein</td>
</tr>
<tr>
<td class="label">CASP8</td>
<td>Protease</td>
</tr
TNF Alpha Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TNF Alpha Protein</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TNF</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Tumor Necrosis Factor Alpha</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P01375</td>
</tr>
<tr>
<td class="label">Length</td>
<td>233 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>25.6 kDa (monomer), 52.4 kDa (trimer)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>6p21.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>7124</td>
</tr>
<tr>
<td class="label">Cellular Localization</td>
<td>Secreted (type II transmembrane protein)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TNF Superfamily</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TNFRSF1A (TNFR1)</td>
<td>Receptor binding</td>
</tr>
<tr>
<td class="label">TNFRSF1B (TNFR2)</td>
<td>Receptor binding</td>
</tr>
<tr>
<td class="label">TNFRSF1B</td>
<td>Decoy receptor</td>
</tr>
<tr>
<td class="label">TRADD</td>
<td>Adapter protein</td>
</tr>
<tr>
<td class="label">RIPK1</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">TRAF2</td>
<td>Adapter protein</td>
</tr>
<tr>
<td class="label">CASP8</td>
<td>Protease</td>
</tr>
<tr>
<td class="label">IKK complex</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">3404 edges</a></td>
</tr>
</table>
Tumor necrosis factor alpha (TNF-α) is a potent pro-inflammatory cytokine that plays a central role in immune regulation, inflammation, and cell survival. As a member of the TNF superfamily, TNF-α is produced primarily by activated macrophages and monocytes, but also by [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), and [neurons](/entities/neurons) in the central nervous system. TNF-α signals through two distinct receptors—TNFR1 (p55) and TNFR2 (p75)—which activate both pro-inflammatory [NF-κB](/entities/nf-kb) signaling and caspase-dependent [apoptosis](/entities/apoptosis) pathways. In neurodegeneration, TNF-α is a key mediator of chronic neuroinflammation, driving disease progression in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and traumatic brain injury.
Overview
TNF-α is synthesized as a 26 kDa type II transmembrane protein that can be shed as a soluble 17 kDa trimer by proteolytic cleavage (TACE/ADAM17). The soluble trimer is the biologically active form that engages TNF receptors with high affinity (Kd ~ 10^-10 M).
Structure
TNF-α adopts a classic β-jelly roll fold characteristic of the TNF family:
- Trimeric assembly: Functional unit is a stable trimer
- β-sandwich fold: Two β-sheets forming a jelly roll topology
- Receptor binding sites: Three receptor binding sites per trimer
Structural Features
Normal Function
Immune System
TNF-α is a master regulator of inflammation:
- Pro-inflammatory signaling: Activates NF-κB and MAPK pathways
- Cell death: Induces apoptosis through caspase-8 activation
- Fever generation: Acts on hypothalamus via prostaglandin production
- Cachexia: Promotes muscle wasting in chronic disease
- Leukocyte recruitment: Induces adhesion molecule expression
Nervous System
In the CNS, TNF-α has complex and context-dependent effects:
- Synaptic plasticity: Modulates glutamatergic signaling and [LTP](/mechanisms/long-term-potentiation)
- Glial activation: Induces astrocyte and microglial inflammatory responses
- [Blood-brain barrier](/entities/blood-brain-barrier): Regulates BBB permeability
- Pain modulation: Sensitizes pain pathways
- Neuroprotection: At low levels, can activate survival pathways
Signaling Pathways
TNF-α activates three major signaling cascades:
Role in Disease
Alzheimer's Disease
TNF-α is a central driver of neuroinflammation in AD:
- Elevated levels: Increased in AD brain, CSF, and plasma
- Plaque interaction: Associates with amyloid plaques
- Synaptic dysfunction: Disrupts synaptic plasticity and memory
- Neuronal death: Promotes excitotoxic and apoptotic pathways
- Therapeutic target: Primary candidate for anti-inflammatory therapy
Parkinson's Disease
In PD, TNF-α mediates dopaminergic degeneration:
- Substantia nigra elevation: High expression in PD brains
- Microglial activation: Sustains chronic neuroinflammation
- Dopaminergic toxicity: Direct and indirect neuronal damage
- [Alpha-synuclein](/proteins/alpha-synuclein): Modulates aggregation and spread
- Genetic links: TNF polymorphisms associated with PD risk
Amyotrophic Lateral Sclerosis
TNF-α contributes to motor neuron degeneration:
- Systemic elevation: Increased in ALS patients
- Motor [cortex](/brain-regions/cortex) involvement: High expression in affected regions
- Glial contribution: Microglial and astrocytic sources
- Disease progression: Correlates with progression rate
Multiple Sclerosis
Central role in demyelination and lesion formation:
- Demyelination: Promotes oligodendrocyte death
- BBB disruption: Increases vascular permeability
- Lesion activity: Accumulates in active MS lesions
- Relapse: Correlates with clinical activity
Traumatic Brain Injury
- Secondary damage: Exacerbates post-injury neurodegeneration
- Excitotoxicity: Amplifies glutamate-induced damage
Therapeutic Targeting
TNF-α is a major drug target with several approved therapies:
Approved Therapies
- Etanercept (Enbrel): TNF receptor-Fc fusion protein
- Infliximab (Remicade): Anti-TNF monoclonal antibody
- Adalimumab (Humira): Anti-TNF monoclonal antibody
- Certolizumab pegol (Cimzia): PEGylated Fab fragment
- Golimumab (Simponi): Anti-TNF monoclonal antibody
Challenges in Neurology
- Blood-brain barrier: TNF inhibitors don't effectively cross BBB
- CNS delivery strategies: Focused ultrasound, intrathecal administration
- Peripheral vs CNS: Differentiating peripheral vs CNS TNF effects
Biomarker Potential
TNF-α serves as a biomarker for neuroinflammation:
- CSF TNF-α: Elevated in AD, PD, ALS, MS
- Plasma/serum: Peripheral marker of systemic inflammation
- Therapeutic monitoring: Tracks anti-inflammatory treatment response
Interaction Network
Key Publications
Pathway & Interaction Diagram
Interactive diagram showing TNF's key relationships in the SciDEX knowledge graph (15 connections shown).
See Also
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
- [TNF Signaling Pathway](/mechanisms/tnf-signaling-pathway)
- [NF-κB Pathway](/mechanisms/nf-kb-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Microglia](/cell-types/microglia)
- [Astrocytes](/cell-types/astrocytes)
External Links
- [UniProt P01375](https://www.uniprot.org/uniprot/P01375)
- [NCBI Gene 7124](https://www.ncbi.nlm.nih.gov/gene/7124)
- [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000228390-TNF)
- [KEGG Pathway: TNF signaling](https://www.kegg.jp/kegg-bin/show_pathway?map04668)
Background
The study of Tnf Alpha Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-tnf-protein |
| kg_node_id | TNFPROTEIN |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-0cbf720e84bf |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-tnf-protein'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-tnf-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[TNF Alpha Protein](http://scidex.ai/artifact/wiki-proteins-tnf-protein)
http://scidex.ai/artifact/wiki-proteins-tnf-protein